Trial intelligence / Profile preview

Ginkgo diterpene lactone meglumine injection vs Ginkgo diterpene lactone meglumine for injection in acute ischemic stroke

CTR20130922Phase 3Completed

Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Ginkgo diterpene lactone meglumine in brain infarction. Started Oct 2013; status: completed.

02

Drugs

Ginkgo diterpene lactone meglumine
03

Conditions

brain infarction

Beyond the preview

Go deeper on CTR20130922.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130922.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call